Stock Comparison

DDD vs SSYS

3D Systems Corp vs Stratasys Ltd

Who's the better investment? Let's break it down.

The Verdict

DDD takes this one.

It's not even close. DDD outscores SSYS by 4.3 points. That's a significant gap in our deep value framework.

Winner
DDD

3D Systems Corp

5.8

out of 10

Proceed with Caution
SSYS

Stratasys Ltd

1.5

out of 10

Distressed

Want to compare any two stocks?

Sign up free — get 3 DVR analyses/day, 1800+ stocks, portfolio roast. No credit card.

Valuation

DDD

Metric

SSYS

$465M

Market Cap

$738M
15.6

P/E Ratio

Lower may indicate better value

-6.9
13.3

Forward P/E

69.3
1.3

Price/Book

N/A

Profitability & Growth

DDD

Metric

SSYS

7.7%

Profit Margin

-18.9%
33.9%

Gross Margin

41.2%
13.4%

Operating Margin

-13.2%
14.1%

Return on Equity

-12.3%
5.3%

Return on Assets

-9.7%
-12.1%

Revenue Growth

-3.7%
$-0.01

EPS

$-1.26

Financial Health

DDD

Metric

SSYS

0.4

Debt-to-Equity

Lower = less leverage

0.0
2.9

Current Ratio

Above 1.0 is healthy

3.6
2.6

Beta

Lower = less volatile

1.8

Risk Comparison

DDD

Overall
Aggressive
Financial
High
Market
Medium
Competitive
High
Execution
Medium
Regulatory
Low

What Could Go Wrong

The Q1 2026 positive Adjusted EBITDA and narrow net loss could be an anomaly if Q2 guidance materializes as projected negative EBITDA. If the company cannot sustain profitability and positive cash flo...

Red Flags

  • 🚩Company remains GAAP unprofitable, with a net loss of $4.4M in Q1 2026.
  • 🚩Q2 2026 guidance forecasts Adjusted EBITDA to return to negative territory (-$4M to -$2M).
  • 🚩Operating cash flow and free cash flow remain negative, indicating ongoing cash burn.

SSYS

Overall
Aggressive
Financial
High
Market
Medium
Competitive
High
Execution
High
Regulatory
Low

What Could Go Wrong

Despite a strong balance sheet and a Q4 2025 EPS beat, Stratasys's FY2026 guidance projects significant losses, indicating continued cash burn. If the company fails to return to sustained profitabilit...

Red Flags

  • 🚩Persistent negative FY2026 EPS guidance ($-0.95 to $-0.76)
  • 🚩Year-over-year revenue decline (-6.9% in Q4 2025) in a growing market
  • 🚩Reported negative net margin (-18.92%) despite positive Q4 EPS, suggesting overall profitability cha...

Competitive Moat

DDD

Rating

🛡️ Narrow

Trend

➡️ Stable. The focus on medical is strengthening its niche, but broad market competition is intense.

Intangible Assets/IP (patented technologies, regulatory approvals for medical applications)Switching Costs (customers invested in specific 3D Systems' hardware and software ecosystems, validated production processes)Efficient Scale (specialized manufacturing capabilities for complex applications)

SSYS

Rating

🛡️ Narrow

Trend

➡️ Eroding/Stable

Intangible Assets/IPSwitching CostsBrand Power

Investment Thesis

DDD5.8/10

3D Systems is a high-risk, high-reward turnaround opportunity within the high-growth additive manufacturing sector. Its Q1 2026 results indicate management is executing effectively on a strategic pivot towards higher-margin healthcare solutions and rigorous cost control, significantly improving profitability metrics. While sustained profitability and positive cash flow are not yet guaranteed, the ...

Full DDD Analysis
SSYS1.5/10

Stratasys, a long-standing innovator in additive manufacturing, could represent a deep value opportunity for aggressive investors if its Q4 2025 EPS beat signals the beginning of a sustained operational turnaround. Its strong balance sheet provides resilience, and new product launches target high-growth areas. If management can effectively execute on its strategy, achieve sustained profitability, ...

Full SSYS Analysis

Price Targets & Strategy

Price Targets & Entry/Exit Strategy

Sign up free to unlock the full comparison

Growth Catalysts

Growth Catalysts Comparison

Sign up free to unlock the full comparison

Market Sentiment

Market Sentiment Analysis

Sign up free to unlock the full comparison

The Deep Dive

DDD5.8/10

3D Systems shows tangible signs of a turnaround, with Q1 2026 revenue beating estimates and, more importantly, Adjusted EBITDA turning positive after a period of persistent unprofitability. The significant reduction in net loss and strong growth in the Healthcare segment (+21% YoY) validate management's strategic pivot and cost-cutting initiatives. While the company remains GAAP unprofitable and Q2 guidance projects a return to negative Adjusted EBITDA, the latest results provide a clearer path ...

Full DDD Analysis
SSYS1.5/10

Stratasys (SSYS) still presents a high-risk, low-reward profile for 10x growth potential, with a slight adjustment from the previous analysis. While Q4 2025 revenue declined -6.9% YoY, the company reported a positive EPS of $0.07, beating estimates, which is a minor positive against previous concerns of worsening unprofitability for that specific quarter. New product launches (PolyJet J850 Core, GrabCAD suite, SAF PA12) indicate continued innovation. The balance sheet remains strong with a curre...

Full SSYS Analysis

Want More Comparisons?

Run any stock through our deep value analyzer.

Not Financial Advice

This comparison is for educational purposes only. We are not financial advisors. Always do your own research and consult a qualified financial advisor before making investment decisions.

New member exclusive offer

Sign up free — members unlock an exclusive 44% off Premium deal